China Pharma Inc. (CPHI) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

China Pharma Inc.

AMEX: CPHI · Real-Time Price · USD
1.91
-0.04 (-2.05%)
At close: Sep 26, 2025, 3:59 PM

China Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
626.88K 1.42M 2.03M 4.86M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
281.07K 728.31K 464.45K 835.4K
Inventory
2.27M 3.73M 2.95M 3.34M
Other Current Assets
n/a n/a 444.64K 471.00
Total Current Assets
3.27M 6M 5.96M 9.09M
Property-Plant & Equipment
4.53M 6.82M 9.61M 12.97M
Goodwill & Intangibles
7.09M 3.65M 2.21M 589.62K
Total Long-Term Assets
11.62M 10.47M 11.82M 13.56M
Total Assets
14.89M 16.47M 17.78M 22.65M
Account Payables
225.11K 966.42K 667.08K 926.75K
Deferred Revenue
162.21K 90.51K 520.29K 210.03K
Short-Term Debt
2.16M 3.1M 8.72M 7.11M
Other Current Liabilities
1.59M 1.26M 372.58K 327.03K
Total Current Liabilities
5.02M 6.82M 12.74M 10.51M
Long-Term Debt
1.39M 1.41M n/a 5.25M
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
2.12M 2.19M 754.7K 6.12M
Total Liabilities
7.14M 9.01M 13.49M 16.63M
Total Debt
3.59M 4.63M 8.76M 12.49M
Book Value
7.75M 7.45M 4.29M 6.02M
Book Value Per Share
0.44 0.70 0.82 1.30
Common Stock
32.62K 10.63K 74.91K 47.34K
Retained Earnings
-44.03M -39.29M -36.21M -32.24M
Comprehensive Income
11.32M 11.45M 11.57M 12.56M
Shareholders Equity
7.75M 7.45M 4.29M 6.02M
Total Investments
198.64K n/a n/a n/a